MAPT and Alzheimer disease: Recent studies have reported that based on a blood test measuring one of the two forms of phosphorylated tau protein (p-tau181 or p-tau217), it is possible to differentially diagnose AD from another neurodegenerative disease with high accuracy [65,66].